Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30901331.
- Also identified by DOI 10.1371/journal.pmed.1002767 and PMC identifier 6430373.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In a Collection Review, Patrick Phillips and colleagues discuss developments in clinical trial design for the evaluation of TB therapeutics.
Medical subject headings
- Antitubercular Agents
- Clinical Trials, Phase III as Topic
- Tuberculosis